美股詳情

本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

SPYRE THERAPEUTICS INC

15.11

+0.45003.07%

盤後：15.110.00000.00%16:24 EDT

成交量：49.99萬

成交額：760.68萬

市值：9.11億

市盈率：-4.75

高：15.63

開：14.95

低：14.66

收：14.66

資料載入中...

總覽公司新聞公告

Spyre Therapeutics, Inc.盤中異動早盤股價大漲5.52%

Spyre Therapeutics, Inc.盤中異動早盤股價大跌5.06%報14.18美元

Spyre Therapeutics, Inc.盤中異動早盤大幅上漲5.30%報14.70美元

Spyre Therapeutics, Inc.盤中異動大幅上漲5.16%報12.85美元

Spyre Therapeutics, Inc.盤中異動早盤急速下挫5.42%報12.65美元

Spyre Therapeutics, Inc.盤中異動早盤股價大漲5.85%

嗡嗡聲--美國股票走勢-沃爾格林、哈雷戴維森、惠普企業

嗡嗡聲--美國股票走勢-Spire Global、Broadcom、AGCO

嗡嗡聲--美國股票走勢-加密股票 , WD-40, 老道明寺

BUZZ-Leerink Partners 開始對 Spyre Therapeutics 進行 "跑贏大盤 "的評級。

Spyre Therapeutics獲Leerink Partners首次覆蓋，給予優於大市評級, 目標價45.00美元。

Spyre Therapeutics, Inc.盤中異動急速下挫6.18%報12.00美元

Spyre Therapeutics, Inc.盤中異動早盤大幅跳水5.75%報14.60美元

Spyre Therapeutics, Inc.盤中異動急速下挫5.14%

Spyre Therapeutics, Inc.盤中異動早盤股價大跌5.21%報18.48美元

Spyre Therapeutics, Inc.2024財年實現淨利潤-1.50億美元，同比減少58.09%

異動解讀 | Spyre Therapeutics Inc盤中大漲6.97%,新藥研發取得重大進展

Spyre Therapeutics, Inc.盤中異動股價大漲6.97%

Spyre Therapeutics, Inc.盤中異動早盤快速上漲8.74%

Spyre Therapeutics(SYRE.US)：2024年Q4財報實現營收0美元，前值為0美元，預期值為233萬美元；每股收益為-0.81美元，前值為-4.05美元，預期值為-0.97美元。

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/SYRE/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"SYRE","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SYRE\",,,,,undefined,":{"symbol":"SYRE","market":"US","secType":"STK","nameCN":"SPYRE THERAPEUTICS INC","latestPrice":15.11,"timestamp":1746216000000,"preClose":14.66,"halted":0,"volume":499897,"hourTrading":{"tag":"盘后","latestPrice":15.11,"preClose":15.11,"latestTime":"16:24 EDT","volume":11745,"amount":177466.68,"timestamp":1746217480365},"delay":0,"floatShares":46620090,"shares":60275561,"eps":-3.180151,"marketStatus":"休市中","change":0.45,"latestTime":"05-02 16:00:00 EDT","open":14.95,"high":15.63,"low":14.66,"amount":7606820.121358,"amplitude":0.066166,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-3.180151,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1746432000000},"marketStatusCode":7,"adr":0,"listingDate":1460001600000,"exchange":"NASDAQ","adjPreClose":14.66,"preHourTrading":{"tag":"盘前","latestPrice":15.47,"preClose":14.66,"latestTime":"09:28 EDT","volume":855,"amount":12451.897665,"timestamp":1746192480030},"postHourTrading":{"tag":"盘后","latestPrice":15.11,"preClose":15.11,"latestTime":"16:24 EDT","volume":11745,"amount":177466.68,"timestamp":1746217480365},"volumeRatio":1.1434873669196768,"impliedVol":1.3561,"impliedVolPercentile":0.888},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SYRE\",,,,,undefined,":{"symbol":"SYRE","floatShares":46620090,"roa":"-27.43%","roe":"-59.28%","lyrEps":-3.180151,"volumeRatio":1.1434873669196768,"shares":60275561,"dividePrice":0,"high":15.63,"amplitude":0.066166,"preClose":14.66,"low":14.66,"week52Low":10.91,"pbRate":"2.52","week52High":40.49,"institutionHeld":0,"latestPrice":15.11,"eps":-3.180151,"divideRate":0,"volume":499897,"delay":0,"ttmEps":-3.180151,"open":14.95,"prevYearClose":23.28,"prevWeekClose":14.13,"prevMonthClose":15.23,"prevQuarterClose":16.135,"fiveDayClose":14.13,"twentyDayClose":13.99,"sixtyDayClose":23.56},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"SYRE\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2530810222","title":"Spyre Therapeutics, Inc.盤中異動 早盤股價大漲5.52%","url":"https://stock-news.laohu8.com/highlight/detail?id=2530810222","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530810222?lang=zh_tw&edition=fundamental","pubTime":"2025-04-28 21:51","pubTimestamp":1745848310,"startTime":"0","endTime":"0","summary":"北京时间2025年04月28日21时51分，Spyre Therapeutics, Inc.股票出现波动，股价大幅拉升5.52%。Spyre Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.90%。其相关个股中，Galmed Pharmaceuticals Ltd.、Cg Oncology, Inc.、Portage Biotech Inc.涨幅较大，Galmed Pharmaceuticals Ltd.、Portage Biotech Inc.、Tharimmune, Inc.较为活跃，换手率分别为1756.80%、351.55%、66.69%，振幅较大的相关个股有Galmed Pharmaceuticals Ltd.、Senti Biosciences, Inc.、Protara Therapeutics, Inc.，振幅分别为27.39%、22.80%、22.69%。Spyre Therapeutics Inc 是一家生物技术公司，旨在通过结合抗体工程、合理的治疗组合和用于患者选择的精准医学方法来创造下一代炎症性肠病  产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250428215150aa2c7cf4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250428215150aa2c7cf4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","LENZ","BK4139","SYRE"],"gpt_icon":0},{"id":"2530137192","title":"Spyre Therapeutics, Inc.盤中異動 早盤股價大跌5.06%報14.18美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2530137192","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530137192?lang=zh_tw&edition=fundamental","pubTime":"2025-04-25 21:53","pubTimestamp":1745589208,"startTime":"0","endTime":"0","summary":"北京时间2025年04月25日21时53分，Spyre Therapeutics, Inc.股票出现波动，股价急速下跌5.06%。Spyre Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为1.02%。Spyre Therapeutics Inc 是一家生物技术公司，旨在通过结合抗体工程、合理的治疗组合和用于患者选择的精准医学方法来创造下一代炎症性肠病  产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042521532897451cd3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042521532897451cd3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SYRE","BK4007","LENZ"],"gpt_icon":0},{"id":"2529681759","title":"Spyre Therapeutics, Inc.盤中異動 早盤大幅上漲5.30%報14.70美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2529681759","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529681759?lang=zh_tw&edition=fundamental","pubTime":"2025-04-23 21:32","pubTimestamp":1745415120,"startTime":"0","endTime":"0","summary":"北京时间2025年04月23日21时32分，Spyre Therapeutics, Inc.股票出现波动，股价急速拉升5.30%。Spyre Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.57%。Spyre Therapeutics Inc 是一家生物技术公司，旨在通过结合抗体工程、合理的治疗组合和用于患者选择的精准医学方法来创造下一代炎症性肠病  产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250423213201aa2c7815&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250423213201aa2c7815&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","LENZ","BK4139","SYRE"],"gpt_icon":0},{"id":"2527167032","title":"Spyre Therapeutics, Inc.盤中異動 大幅上漲5.16%報12.85美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2527167032","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527167032?lang=zh_tw&edition=fundamental","pubTime":"2025-04-14 22:02","pubTimestamp":1744639354,"startTime":"0","endTime":"0","summary":"北京时间2025年04月14日22时02分，Spyre Therapeutics, Inc.股票出现异动，股价快速拉升5.16%。Spyre Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.21%。Spyre Therapeutics, Inc.公司简介：Spyre Therapeutics Inc 是一家生物技术公司，旨在通过结合抗体工程，合理的治疗组合和精确的医学方法来为患者选择，创造下一代炎症性肠病产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025041422023497378a77&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025041422023497378a77&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","LENZ","BK4139","SYRE"],"gpt_icon":0},{"id":"2526560065","title":"Spyre Therapeutics, Inc.盤中異動 早盤急速下挫5.42%報12.65美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2526560065","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526560065?lang=zh_tw&edition=fundamental","pubTime":"2025-04-10 21:37","pubTimestamp":1744292274,"startTime":"0","endTime":"0","summary":"北京时间2025年04月10日21时37分，Spyre Therapeutics, Inc.股票出现波动，股价急速下挫5.42%。Spyre Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为1.08%。Spyre Therapeutics, Inc.公司简介：Spyre Therapeutics Inc 是一家生物技术公司，旨在通过结合抗体工程，合理的治疗组合和精确的医学方法来为患者选择，创造下一代炎症性肠病产品。消息层面，截至21时37分，《Spyre Therapeutics获Leerink Partners首次覆盖，给予优于大市评级, 目标价45.00美元。》资讯为影响Spyre Therapeutics, Inc.的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025041021375497345476&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025041021375497345476&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SYRE","LENZ","BK4139","BK4007"],"gpt_icon":0},{"id":"2526959663","title":"Spyre Therapeutics, Inc.盤中異動 早盤股價大漲5.85%","url":"https://stock-news.laohu8.com/highlight/detail?id=2526959663","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526959663?lang=zh_tw&edition=fundamental","pubTime":"2025-04-09 21:33","pubTimestamp":1744205633,"startTime":"0","endTime":"0","summary":"北京时间2025年04月09日21时33分，Spyre Therapeutics, Inc.股票出现波动，股价快速拉升5.85%。Spyre Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为1.34%。Spyre Therapeutics, Inc.公司简介：Spyre Therapeutics Inc 是一家生物技术公司，旨在通过结合抗体工程，合理的治疗组合和精确的医学方法来为患者选择，创造下一代炎症性肠病产品。消息层面，截至21时33分，《Spyre Therapeutics获Leerink Partners首次覆盖，给予优于大市评级, 目标价45.00美元。》资讯为影响Spyre Therapeutics, Inc.的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250409213353a453d596&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250409213353a453d596&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4139","LENZ","SYRE"],"gpt_icon":0},{"id":"2526184175","title":"嗡嗡聲--美國股票走勢-沃爾格林、哈雷戴維森、惠普企業","url":"https://stock-news.laohu8.com/highlight/detail?id=2526184175","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526184175?lang=zh_tw&edition=fundamental","pubTime":"2025-04-09 02:30","pubTimestamp":1744137010,"startTime":"0","endTime":"0","summary":".N 美国东部时间13:30，道琼斯工业平均指数.DJI上涨0.10%，报38,001.94点。标准普尔500指数.SPX下跌0.41%，报5042.61点；纳斯达克综合指数.IXIC下跌0.63%，报15500.13点。nL3N3QM153  ** KKR & Co Inc KKR.N： ** Icahn Enterprises LP IEP.O： ** 贝莱德公司 BLK.N： ** Charles Schwab Corp SCHW.N： BUZZ - 美国资产管理公司上涨，市场","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250408:nL3S3QM1JU:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TRGP","NEM","RPM","AGCO","AFRM","SUI","CVS","HUM","SYRE","ELV","MA","CVX","IEP","RIOT","CNC","SCHW","XOM","BTU","BLK","LEVI","JHG","UNP","WY","LU1119994496.HKD","KMI","CNR","LU1791710582.SGD","WDFC","HPE","LU1489326972.SGD","LU0949170772.SGD","ODFL","STRK","AXP","HOG","LMND","KKR","TLRY","IE00BYXW3230.USD","LU0162691827.USD","SPIR","WBA"],"gpt_icon":1},{"id":"2526453458","title":"嗡嗡聲--美國股票走勢-Spire Global、Broadcom、AGCO","url":"https://stock-news.laohu8.com/highlight/detail?id=2526453458","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526453458?lang=zh_tw&edition=fundamental","pubTime":"2025-04-09 00:53","pubTimestamp":1744131199,"startTime":"0","endTime":"0","summary":".N  美国东部时间11:30，道琼斯工业平均指数.DJI上涨1.97%，报38,713.36点；标准普尔500指数.SPX上涨1.95%，报5,160.92点；纳斯达克综合指数.IXIC上涨2.29%，报15,961.33点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250408:nL3T3QM1H4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CVX","LU0494093205.USD","SPIR","WBA","LEVI","ELV","HOG","LU0353189763.USD","KMI","CVS","NEM","UNP","TRGP","TLRY","LMND","LU1732799900.SGD","WDFC","ODFL","SYRE","STRK","SGXZ51526630.SGD","AXP","HUM","AVGO","SCHW","BTU","LU0006306889.USD","AGCO","LU2756315318.SGD","RPM","BLK","CNR","KKR","IEP","LU0011850046.USD","XOM","RIOT","LU0345769128.USD","CNC","LU0912757837.SGD","MA","JHG","LU0211328371.USD"],"gpt_icon":1},{"id":"2525438897","title":"嗡嗡聲--美國股票走勢-加密股票 , WD-40, 老道明寺","url":"https://stock-news.laohu8.com/highlight/detail?id=2525438897","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525438897?lang=zh_tw&edition=fundamental","pubTime":"2025-04-08 21:14","pubTimestamp":1744118048,"startTime":"0","endTime":"0","summary":".N** NIO Inc < NIO.N  >:BUZZ - 报导称CATL正在洽谈收购该公司的电力部门，港股因此上涨。nL3N3QM153 (为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250408:nL3T3QM16W:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HUM","LU0516423174.USD","CNC","NIO.SI","ODFL","LU0878004406.USD","SYRE","XOM","WDFC","STRK","TME","LU1066051498.USD","CVS","MA","LU1633808545.USD","LU0640476718.USD","TLRY","LU0320765489.SGD","WBA","80700","BK4107","COP","RIOT","APA","UNP","EVS.SI","HTCD.SI","LEVI","NEM","LU2023250843.SGD","LU1035773651.USD","01698","LMND","LU0823038988.USD","LU1366192091.USD","CVX","RPM","AXP"],"gpt_icon":1},{"id":"2525925268","title":"BUZZ-Leerink Partners 開始對 Spyre Therapeutics 進行 \"跑贏大盤 \"的評級。","url":"https://stock-news.laohu8.com/highlight/detail?id=2525925268","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525925268?lang=zh_tw&edition=fundamental","pubTime":"2025-04-08 20:57","pubTimestamp":1744117079,"startTime":"0","endTime":"0","summary":"4月8日 - ** 生物技术公司Spyre Therapeutics的SYRE.O股价盘前上涨3%至12.76美元 ** 券商Leerink Partners给予该公司 \"跑赢大盘 \"的评级 ** 将目标价定为45美元，与该股上次收盘价相比，上涨幅度超过三倍 ** Leerink Partners 认为 SYRE 是 \"炎症性肠病领域最有吸引力的潜在进入者之一\"。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250408:nL3T3QM160:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SYRE"],"gpt_icon":0},{"id":"2525891739","title":"Spyre Therapeutics獲Leerink Partners首次覆蓋，給予優於大市評級, 目標價45.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2525891739","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525891739?lang=zh_tw&edition=fundamental","pubTime":"2025-04-08 20:04","pubTimestamp":1744113858,"startTime":"0","endTime":"0","summary":"Spyre Therapeutics(SYRE.US)获Leerink Partners首次覆盖，给予优于大市评级, 目标价45.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025040820114694cf8697&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025040820114694cf8697&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SYRE","LENZ"],"gpt_icon":0},{"id":"2525602842","title":"Spyre Therapeutics, Inc.盤中異動 急速下挫6.18%報12.00美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2525602842","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525602842?lang=zh_tw&edition=fundamental","pubTime":"2025-04-07 21:30","pubTimestamp":1744032656,"startTime":"0","endTime":"0","summary":"北京时间2025年04月07日21时30分，Spyre Therapeutics, Inc.股票出现异动，股价大幅跳水6.18%。Spyre Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。Spyre Therapeutics, Inc.公司简介：Spyre Therapeutics Inc 是一家生物技术公司，旨在通过结合抗体工程，合理的治疗组合和精确的医学方法来为患者选择，创造下一代炎症性肠病产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250407213056a450fa68&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250407213056a450fa68&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SYRE","BK4007","LENZ","BK4139"],"gpt_icon":0},{"id":"2524265241","title":"Spyre Therapeutics, Inc.盤中異動 早盤大幅跳水5.75%報14.60美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2524265241","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524265241?lang=zh_tw&edition=fundamental","pubTime":"2025-04-03 21:32","pubTimestamp":1743687122,"startTime":"0","endTime":"0","summary":"北京时间2025年04月03日21时32分，Spyre Therapeutics, Inc.股票出现异动，股价快速跳水5.75%。Spyre Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.35%。Spyre Therapeutics, Inc.公司简介：Spyre Therapeutics Inc 是一家生物技术公司，旨在通过结合抗体工程，合理的治疗组合和精确的医学方法来为患者选择，创造下一代炎症性肠病产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250403213202a6ae96cd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250403213202a6ae96cd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","SYRE"],"gpt_icon":0},{"id":"2519885171","title":"Spyre Therapeutics, Inc.盤中異動 急速下挫5.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2519885171","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519885171?lang=zh_tw&edition=fundamental","pubTime":"2025-03-14 00:23","pubTimestamp":1741882984,"startTime":"0","endTime":"0","summary":"北京时间2025年03月14日00时23分，Spyre Therapeutics, Inc.股票出现异动，股价大幅跳水5.14%。Spyre Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.14%。Spyre Therapeutics, Inc.公司简介：Spyre Therapeutics Inc 是一家生物技术公司，旨在通过结合抗体工程，合理的治疗组合和精确的医学方法来为患者选择，创造下一代炎症性肠病产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031400230498a675cb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031400230498a675cb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","SYRE"],"gpt_icon":0},{"id":"2518327167","title":"Spyre Therapeutics, Inc.盤中異動 早盤股價大跌5.21%報18.48美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518327167","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518327167?lang=zh_tw&edition=fundamental","pubTime":"2025-03-10 22:36","pubTimestamp":1741617373,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日22时36分，Spyre Therapeutics, Inc.股票出现波动，股价大幅跳水5.21%。Spyre Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.02%。Spyre Therapeutics, Inc.公司简介：Spyre Therapeutics Inc 是一家生物技术公司，旨在通过结合抗体工程，合理的治疗组合和精确的医学方法来为患者选择，创造下一代炎症性肠病产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310223613abf314b3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310223613abf314b3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","SYRE"],"gpt_icon":0},{"id":"2518440864","title":"Spyre Therapeutics, Inc.2024財年實現淨利潤-1.50億美元，同比減少58.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518440864","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518440864?lang=zh_tw&edition=fundamental","pubTime":"2025-03-09 00:00","pubTimestamp":1741449622,"startTime":"0","endTime":"0","summary":"3月9日，Spyre Therapeutics, Inc.公布财报，公告显示公司2024财年净利润为-1.50亿美元，同比减少58.09%；其中营业收入为0.00美元，每股基本收益为-3.18美元。从资产负债表来看，Spyre Therapeutics, Inc.总负债90.68百万美元，其中短期债务0.00美元，资产负债比为0.07，流动比率为0.12。机构评级：截至2025年3月9日，当前有8家机构对Spyre Therapeutics, Inc.目标价做出预测，其中目标均价为58.62美元，其中最低目标价为40.00美元，最高目标价为71.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250309000037abef96fe&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250309000037abef96fe&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","SYRE"],"gpt_icon":0},{"id":"1196051233","title":"異動解讀 | Spyre Therapeutics Inc盤中大漲6.97%,新藥研發取得重大進展","url":"https://stock-news.laohu8.com/highlight/detail?id=1196051233","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1196051233?lang=zh_tw&edition=fundamental","pubTime":"2025-03-05 23:08","pubTimestamp":1741187300,"startTime":"0","endTime":"0","summary":"Spyre Therapeutics Inc作为一家专注于新型肠病药物研发的生物技术公司,周三盘中出现了6.97%的大涨行情,引发了市场的广泛关注。分析人士指出,SYRE股价大涨的原因可能与该公司最新研发进展有关。SYRE的这款新药主打免疫调节作用,与现有主流药物采用不同的治疗机理,预计上市后将给这一疾病领域带来全新的治疗选择。随着临床数据的持续披露,投资者对新药未来前景的信心不断增强,这也是推动SYRE股价持续走高的主要原因。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"异动解读 | Spyre Therapeutics Inc盘中大涨6.97%,新药研发取得重大进展","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["SYRE"],"gpt_icon":0},{"id":"2517943943","title":"Spyre Therapeutics, Inc.盤中異動 股價大漲6.97%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517943943","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517943943?lang=zh_tw&edition=fundamental","pubTime":"2025-03-05 22:32","pubTimestamp":1741185121,"startTime":"0","endTime":"0","summary":"北京时间2025年03月05日22时32分，Spyre Therapeutics, Inc.股票出现异动，股价快速拉升6.97%。Spyre Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.21%。Spyre Therapeutics, Inc.公司简介：Spyre Therapeutics Inc 是一家生物技术公司，旨在通过结合抗体工程，合理的治疗组合和精确的医学方法来为患者选择，创造下一代炎症性肠病产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305223201963adc60&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305223201963adc60&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SYRE","LENZ"],"gpt_icon":0},{"id":"2514781803","title":"Spyre Therapeutics, Inc.盤中異動 早盤快速上漲8.74%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514781803","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514781803?lang=zh_tw&edition=fundamental","pubTime":"2025-02-28 22:31","pubTimestamp":1740753076,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日22时31分，Spyre Therapeutics, Inc.股票出现波动，股价快速拉升8.74%。Spyre Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.02%。Spyre Therapeutics, Inc.公司简介：Spyre Therapeutics Inc 是一家生物技术公司，旨在通过结合抗体工程，合理的治疗组合和精确的医学方法来为患者选择，创造下一代炎症性肠病产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228223116a25800d2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228223116a25800d2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","SYRE"],"gpt_icon":0},{"id":"2514516354","title":"Spyre Therapeutics(SYRE.US)：2024年Q4財報實現營收0美元，前值為0美元，預期值為233萬美元；每股收益為-0.81美元，前值為-4.05美元，預期值為-0.97美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2514516354","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514516354?lang=zh_tw&edition=fundamental","pubTime":"2025-02-28 07:08","pubTimestamp":1740697720,"startTime":"0","endTime":"0","summary":"Spyre Therapeutics(SYRE.US)：2024年Q4财报实现营收0美元，前值为0美元，预期值为233万美元；每股收益为-0.81美元，前值为-4.05美元，预期值为-0.97美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/28070848442547.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["LENZ","SYRE"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":40,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/SYRE\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-02-27","symbol":"SYRE","fiscalQuarterEnding":"2024/12","expectedEps":-1.1,"name":null,"time":"盤後","type":"earning","dateTimestamp":1740632400000,"reportTimeType":"post","actualEps":-0.81},{"market":"US","date":"2024-11-07","symbol":"SYRE","fiscalQuarterEnding":"2024/09","expectedEps":-0.8,"name":null,"time":"盤後","type":"earning","dateTimestamp":1730955600000,"reportTimeType":"post","actualEps":-1.36},{"market":"US","date":"2024-08-07","symbol":"SYRE","fiscalQuarterEnding":"2024/06","expectedEps":-0.9,"name":null,"time":"盤後","type":"earning","dateTimestamp":1723003200000,"reportTimeType":"post","actualEps":-0.86},{"market":"US","date":"2024-05-09","symbol":"SYRE","fiscalQuarterEnding":"2024/03","expectedEps":-0.9,"name":null,"time":"盤後","type":"earning","dateTimestamp":1715227200000,"reportTimeType":"post","actualEps":-1.2},{"market":"US","date":"2024-02-29","symbol":"SYRE","fiscalQuarterEnding":"2023/12","expectedEps":-0.48,"name":null,"time":"盤後","type":"earning","dateTimestamp":1709182800000,"reportTimeType":"post","actualEps":-2.28}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"SYRE\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"SYRE\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.6667,"buy":0.25,"hold":0.0833,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":0.6667,"analysts":12,"updateTime":1744171200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/SYRE\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"SYRE","date":"2025-05-01","current":-4.413064,"percent":0.528358,"low":-10.261647,"twenty":-7.371109,"median":-4.789976,"eighty":-3.456852,"high":-0.199399,"avg":-5.185138,"sd":2.040117,"marketCap":917996794},"quantilePoints":[{"date":"2023-12-01","current":-1.902619,"twenty":-1.228042,"median":-0.216176,"eighty":-0.20611,"marketCap":560191990},{"date":"2023-12-08","current":-2.024974,"twenty":-2.048834,"median":-1.98164,"eighty":-0.890753,"marketCap":596217199},{"date":"2023-12-15","current":-1.815535,"twenty":-2.023412,"median":-1.966856,"eighty":-1.735642,"marketCap":534551743},{"date":"2023-12-22","current":-2.106706,"twenty":-2.023412,"median":-1.950531,"eighty":-1.82549,"marketCap":620281740},{"date":"2023-12-29","current":-2.507984,"twenty":-2.09023,"median":-1.996425,"eighty":-1.840422,"marketCap":738430643},{"date":"2024-01-05","current":-2.757559,"twenty":-2.278228,"median":-2.002935,"eighty":-1.873937,"marketCap":811913497},{"date":"2024-01-12","current":-2.567931,"twenty":-2.588728,"median":-2.024974,"eighty":-1.89995,"marketCap":756080936},{"date":"2024-01-19","current":-2.66458,"twenty":-2.653814,"median":-2.09023,"eighty":-1.902486,"marketCap":784537532},{"date":"2024-01-26","current":-3.303198,"twenty":-2.742878,"median":-2.292052,"eighty":-1.915254,"marketCap":972567189},{"date":"2024-02-02","current":-3.16373,"twenty":-3.116751,"median":-2.567931,"eighty":-1.947266,"marketCap":931503241},{"date":"2024-02-09","current":-2.89825,"twenty":-3.138772,"median":-2.61809,"eighty":-1.978684,"marketCap":853337655},{"date":"2024-02-16","current":-2.760005,"twenty":-3.112591,"median":-2.66458,"eighty":-1.997649,"marketCap":812633917},{"date":"2024-02-23","current":-2.496973,"twenty":-3.08641,"median":-2.66458,"eighty":-2.000865,"marketCap":735188752},{"date":"2024-03-01","current":-3.357028,"twenty":-3.117974,"median":-2.696389,"eighty":-2.009323,"marketCap":988416432},{"date":"2024-03-08","current":-4.14553,"twenty":-3.186241,"median":-2.748383,"eighty":-2.021849,"marketCap":1404464057},{"date":"2024-03-15","current":-4.473117,"twenty":-3.315921,"median":-2.757559,"eighty":-2.032927,"marketCap":1515447446},{"date":"2024-03-22","current":-4.253303,"twenty":-3.374155,"median":-2.84075,"eighty":-2.069838,"marketCap":1440976508},{"date":"2024-03-28","current":-3.948124,"twenty":-3.948124,"median":-2.884793,"eighty":-2.09023,"marketCap":1337584817},{"date":"2024-04-05","current":-3.822655,"twenty":-3.997689,"median":-2.933117,"eighty":-2.106706,"marketCap":1295077328},{"date":"2024-04-12","current":-4.169482,"twenty":-4.017483,"median":-2.950857,"eighty":-2.22293,"marketCap":1412578691},{"date":"2024-04-19","current":-3.844264,"twenty":-4.019298,"median":-3.071974,"eighty":-2.361175,"marketCap":1302398285},{"date":"2024-04-26","current":-3.508242,"twenty":-4.017483,"median":-3.149049,"eighty":-2.496973,"marketCap":1188557401},{"date":"2024-05-03","current":-4.312212,"twenty":-4.026871,"median":-3.180093,"eighty":-2.505537,"marketCap":1460934345},{"date":"2024-05-10","current":-4.183809,"twenty":-4.050631,"median":-3.290964,"eighty":-2.507984,"marketCap":1417432578},{"date":"2024-05-17","current":-4.180278,"twenty":-4.096445,"median":-3.334395,"eighty":-2.567931,"marketCap":1522561849},{"date":"2024-05-24","current":-3.614061,"twenty":-4.096445,"median":-3.364368,"eighty":-2.569154,"marketCap":1316331249},{"date":"2024-05-31","current":-3.765942,"twenty":-4.092735,"median":-3.38639,"eighty":-2.608303,"marketCap":1371650246},{"date":"2024-06-07","current":-4.825529,"twenty":-4.146052,"median":-3.527045,"eighty":-2.61809,"marketCap":1757578310},{"date":"2024-06-14","current":-4.511821,"twenty":-4.180278,"median":-3.580903,"eighty":-2.629835,"marketCap":1643317946},{"date":"2024-06-21","current":-3.573485,"twenty":-4.180278,"median":-3.584639,"eighty":-2.648431,"marketCap":1301552501},{"date":"2024-06-28","current":-3.166361,"twenty":-4.18028,"median":-3.584639,"eighty":-2.659197,"marketCap":1153267940},{"date":"2024-07-05","current":-3.59161,"twenty":-4.180278,"median":-3.582547,"eighty":-2.666048,"marketCap":1308154211},{"date":"2024-07-12","current":-3.922049,"twenty":-4.1738,"median":-3.59161,"eighty":-2.678038,"marketCap":1428508461},{"date":"2024-07-15","current":-4.13816,"twenty":-4.171641,"median":-3.593701,"eighty":-2.681708,"marketCap":1507221157},{"date":"2024-08-02","current":-3.753344,"twenty":-4.169482,"median":-3.595793,"eighty":-2.685378,"marketCap":1367061777},{"date":"2024-08-09","current":-6.895906,"twenty":-4.180278,"median":-3.619566,"eighty":-2.707399,"marketCap":1282507443},{"date":"2024-08-16","current":-7.250942,"twenty":-4.233229,"median":-3.6476,"eighty":-2.720856,"marketCap":1348537529},{"date":"2024-08-23","current":-6.762084,"twenty":-4.253955,"median":-3.674487,"eighty":-2.748383,"marketCap":1257619180},{"date":"2024-08-30","current":-7.666062,"twenty":-4.345056,"median":-3.707046,"eighty":-2.757559,"marketCap":1425741938},{"date":"2024-09-06","current":-7.657869,"twenty":-4.411655,"median":-3.73151,"eighty":-2.757559,"marketCap":1424218166},{"date":"2024-09-13","current":-7.786586,"twenty":-4.705472,"median":-3.759643,"eighty":-2.757559,"marketCap":1448156979},{"date":"2024-09-20","current":-8.323214,"twenty":-4.847589,"median":-3.822655,"eighty":-2.759516,"marketCap":1547959640},{"date":"2024-09-27","current":-7.956335,"twenty":-5.135333,"median":-3.898142,"eighty":-2.824601,"marketCap":1479727208},{"date":"2024-10-04","current":-7.76742,"twenty":-6.713509,"median":-3.922049,"eighty":-2.854452,"marketCap":1444592598},{"date":"2024-10-11","current":-7.452562,"twenty":-6.898091,"median":-3.929227,"eighty":-2.87941,"marketCap":1386034914},{"date":"2024-10-18","current":-8.969358,"twenty":-7.252035,"median":-3.990015,"eighty":-2.895559,"marketCap":1668130191},{"date":"2024-10-25","current":-9.226721,"twenty":-7.3874,"median":-4.004712,"eighty":-2.923697,"marketCap":1715994732},{"date":"2024-10-31","current":-9.352664,"twenty":-7.525937,"median":-4.015348,"eighty":-2.933729,"marketCap":1739417806},{"date":"2024-11-08","current":-8.930417,"twenty":-7.599425,"median":-4.026871,"eighty":-2.936176,"marketCap":1919164435},{"date":"2024-11-15","current":-7.483663,"twenty":-7.650222,"median":-4.048996,"eighty":-2.944985,"marketCap":1608254249},{"date":"2024-11-22","current":-7.375771,"twenty":-7.638736,"median":-4.07743,"eighty":-3.008113,"marketCap":1585067940},{"date":"2024-11-29","current":-7.766414,"twenty":-7.641472,"median":-4.091807,"eighty":-3.046772,"marketCap":1669017834},{"date":"2024-12-06","current":-6.979665,"twenty":-7.646653,"median":-4.11994,"eighty":-3.06708,"marketCap":1499943921},{"date":"2024-12-13","current":-6.534387,"twenty":-7.641035,"median":-4.14553,"eighty":-3.107208,"marketCap":1404252782},{"date":"2024-12-20","current":-6.318577,"twenty":-7.622349,"median":-4.17488,"eighty":-3.133634,"marketCap":1357874868},{"date":"2024-12-27","current":-6.575363,"twenty":-7.605285,"median":-4.180282,"eighty":-3.151985,"marketCap":1413058715},{"date":"2025-01-03","current":-6.515264,"twenty":-7.602508,"median":-4.208519,"eighty":-3.16373,"marketCap":1400143347},{"date":"2025-01-10","current":-6.561704,"twenty":-7.598137,"median":-4.247699,"eighty":-3.165835,"marketCap":1410123404},{"date":"2025-01-17","current":-5.613781,"twenty":-7.595453,"median":-4.253955,"eighty":-3.16915,"marketCap":1206412821},{"date":"2025-01-24","current":-5.957984,"twenty":-7.590053,"median":-4.295985,"eighty":-3.182143,"marketCap":1280382658},{"date":"2025-01-31","current":-6.083645,"twenty":-7.581791,"median":-4.354133,"eighty":-3.191991,"marketCap":1307387519},{"date":"2025-02-07","current":-6.517996,"twenty":-7.571599,"median":-4.396289,"eighty":-3.243978,"marketCap":1400730409},{"date":"2025-02-14","current":-6.195648,"twenty":-7.5588,"median":-4.51381,"eighty":-3.285739,"marketCap":1331457069},{"date":"2025-02-21","current":-6.12189,"twenty":-7.543691,"median":-4.721977,"eighty":-3.295858,"marketCap":1315606390},{"date":"2025-02-28","current":-5.184327,"twenty":-7.527033,"median":-4.825529,"eighty":-3.30956,"marketCap":1078433261},{"date":"2025-03-07","current":-5.940106,"twenty":-7.521557,"median":-4.885482,"eighty":-3.331336,"marketCap":1235649000},{"date":"2025-03-14","current":-5.224396,"twenty":-7.515906,"median":-5.129477,"eighty":-3.352623,"marketCap":1086768364},{"date":"2025-03-21","current":-5.259167,"twenty":-7.500881,"median":-5.171542,"eighty":-3.359964,"marketCap":1094001432},{"date":"2025-03-28","current":-5.125877,"twenty":-7.471223,"median":-5.184327,"eighty":-3.369262,"marketCap":1066274674},{"date":"2025-04-04","current":-4.052513,"twenty":-7.451349,"median":-5.158757,"eighty":-3.380517,"marketCap":842995751},{"date":"2025-04-11","current":-3.456852,"twenty":-7.428767,"median":-5.125877,"eighty":-3.399507,"marketCap":719087442},{"date":"2025-04-17","current":-3.598835,"twenty":-7.393254,"median":-4.931737,"eighty":-3.419927,"marketCap":748622467},{"date":"2025-04-25","current":-4.326136,"twenty":-7.374839,"median":-4.857093,"eighty":-3.429694,"marketCap":899914125},{"date":"2025-05-01","current":-4.413064,"twenty":-7.371109,"median":-4.789976,"eighty":-3.456852,"marketCap":917996794}],"updateTime":1746256063078}}}